Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D02UXK
|
||||
Former ID |
DIB014211
|
||||
Drug Name |
MBX-3254
|
||||
Synonyms |
MBX-3254; GPR119 follow-on compounds (diabetes); GPR119 follow-on compounds (diabetes), Metabolex; MBX-2982 follow-on compounds (diabetes), Metabolex
|
||||
Indication | Non-insulin dependent diabetes [ICD10:E11.9] | Investigative | [543393] | ||
Company |
Metabolex Inc
|
||||
Target and Pathway | |||||
Target(s) | Glucose-dependent insulinotropic receptor | Target Info | Modulator | [543393] | |
KEGG Pathway | cAMP signaling pathway | ||||
Insulin secretion | |||||
WikiPathways | Incretin Synthesis, Secretion, and Inactivation | ||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.